Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 4.7 % |
3 Month Return | + 7.37 % |
1 Year Return | + 80.68 % |
Market Stats | |
Previous Close | ₹286.20 |
Open | ₹286.70 |
Volume | 5.07L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹2,634.19Cr |
P/E Ratio | 49.77 |
PEG Ratio | 272.13 |
Market Cap | ₹2,634.19 Cr |
P/B Ratio | 7.52 |
EPS | 4.73 |
Dividend Yield | 0.23 |
Sector | Pharmaceuticals |
ROE | 9.59 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,634.19 Cr | 215.36% | 0.62 | ₹43 Cr | ₹381 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Themis Medicare Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Themis Medicare Ltd
Themis Medicare plans to merge with Gujarat Themis Biosyn, subject to various regulatory approvals. The merger aims to enhance operational efficiency and create shareholder value.
Themis Medicare Reports Mixed Financial Results - 28 Oct, 2024
Themis Medicare's September 2024 net sales fell 4.95% to Rs 99.59 crore, while net profit rose 39.04% to Rs 9.87 crore. EBITDA increased by 19.88%. EPS decreased significantly. The stock has shown strong returns over the past year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, THEMISMED stock has moved up by 5.2%
FII Holding Up
Foreign Institutions have increased holdings from 0.05% to 0.10% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 67.15% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 32.79% to 32.74% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 24.68 Cr → 14.29 Cr (in ₹), with an average decrease of 42.1% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 129.93 Cr → 122.57 Cr (in ₹), with an average decrease of 5.7% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 67.15% | 0.00 | |
Foreign Institutions | 0.1% | 92.47 | |
Mutual Funds | 0% | 80.00 | |
Retail Investors | 32.74% | ||
Others | 0.01% | 5.56 |
Themis Medicare Ltd in the last 5 years
Lowest (-95.26x)
December 27, 2019
Today (49.77x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (85.14x)
January 23, 2018
Themis Medicare Ltd’s net profit jumped 26.24% since last year same period to ₹14.29Cr in the Q2 2024-2025. On a quarterly growth basis, Themis Medicare Ltd has generated -42.1% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Themis Medicare Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.17%.
Read More about DividendsBearish
Neutral
Bullish
Themis Medicare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Themis Medicare Ltd (THEMISMED) share price today is ₹287.7
Themis Medicare Ltd is listed on NSE
Themis Medicare Ltd is listed on BSE
PE Ratio of Themis Medicare Ltd is 49.77
PE ratio = Themis Medicare Ltd Market price per share / Themis Medicare Ltd Earnings per share
Today’s traded volume of Themis Medicare Ltd(THEMISMED) is 5.07L.
Today’s market capitalisation of Themis Medicare Ltd(THEMISMED) is ₹2634.19Cr.
Themis Medicare Ltd(THEMISMED | Price |
---|---|
52 Week High | ₹317 |
52 Week Low | ₹152.8 |
Themis Medicare Ltd(THEMISMED) share price is ₹287.7. It is down -9.24% from its 52 Week High price of ₹317
Themis Medicare Ltd(THEMISMED) share price is ₹287.7. It is up 88.29% from its 52 Week Low price of ₹152.8
Themis Medicare Ltd(THEMISMED | Returns |
---|---|
1 Day Returns | 1.5% |
1 Month Returns | 4.7% |
3 Month Returns | 7.37% |
1 Year Returns | 80.68% |